To date there is not an established therapy for hepatic fibrosis, then we believe CB1 silencing using shRNA launched by hydrodynamics transfection could exert important antifibrogenic effects, time-limiting the transfection to liver and avoiding its brain transfection. This evidence concerns the gene CNR1 and Hepatic fibrosis.